The localized hydrolysis of basement membrane is thought to be one of several steps that occur during the dissemination of tumour cells in vivo [l].
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Enzymes potentially capable of bringing about such hydrolysis include: matrix metalloproteinases (MMPs) such as the stromelysins, gelatinases (also referred to as type IV collagenases) and matrilysin, or serine proteinases such as plasmin, and the lysosoma1 proteinases cathepsins B and D [2-41. The MMPs consist of a family of nine structurally related enzymes. At physiological pH they have the combined ability to degrade the structural proteins -collagens, proteoglycan, fibronectin and lamininthat play a part in maintaining the integrity of connective tissue [ s] . Increased metalloproteinase expression has been correlated with the invasiveness of several tumour types, and the down-regulation of these enzymes by genetic means is reported to reduce both the invasiveness and metastatic potential of manipulated cell lines [6] . Further evidence for a role for the metalloproteinases in these processes comes from the finding that the tissue metalloproteinase inhibitors (TIMPs) TIMP-1 and TIMP-2 are capable of blocking cell invasion in vitro and that the administration of TIMP-1, or a synthetic metalloproteinase inhibitor, prevents metastasis in simple lung colonization models in vivo [6] . The mature secreted form of the MMPs is Abbreviations used: MMP, matrix metalloproteinase; TIMP, tissue inhibitor of metalloproteinase. comprised of two or more functionally defined domains that are depicted in Figure 1 .
In addition to tight transcriptional regulation, the MMPs are controlled extracellularly, since they are secreted as latent proenzymes. These may be processed to active forms through autocatalytic removal of the propeptide [S, 71. Once activated, these enzymes are susceptible to inhibition by the tight non-covalently binding TIMPs [S] . The autocatalytic activation event does not occur unless the propeptide is perturbed and it is thought that in vivo this may arise by propeptide clipping, by proteases such as plasmin. Gelatinase-A is unlike the other enzymes in that its activation cannot be initiated by such proteases [8] . The only clue to its activation in vivo is the finding that it can be activated by a membrane component of cells after stimulation with effectors such as concanavalin A, cytochalasin D, phorbol esters, transforming growth factor /3 (TGFB) or by plating cells on collagen [9-121. We have recently shown that activation of gelatinase-A by cell membranes requires the enzyme to have an intact C-terminal domain [13] , and it has been proposed that the interaction of gelatinase-A, through its C-terminal domain, with cell membranes leads to its autoproteolytic activation [13, 141. Since we know that TIMP-2 also binds to this domain in the proenzyme [13-161, and can block activation by cell membranes [12, 141, we proposed that a role for TIMP-2 in vivo might be to prevent progelatinase-A from having which is the catalytic domain containing the conserved sequence HE(I/UF)GH. By analogy with thermolysin this may be involved in co-ordinating the zinc atom at the active site. In both gelatinases, this domain also contains an inserted sequence that shares sequence similarity with the collagenbinding domain of fibronectin (domain 4). At the C-terminal end of the gelatinase-B catalytic domain there is an additional insert (domain 5) that has some similarity with amino acid sequences found within a number of collagens. Domain 3, which is absent in matrilysin, shares sequence homology with hemopexin and vitronectin, and is linked to domain 2 by a proline-rich sequence of 5-10 amino acids. access to sites of activation on the cell surface [13] .
In fact, gelatinase-A has been purified from tumour cell lines in association with the plasma membrane We have found that binding of progelatinase-A to concanavalin A-stimulated fibroblasts requires an intact C-terminal domain, and that binding can be blocked by either TIMP-2 or competition with purified C-terminal domain (G. Murphy and R. Ward, unpublished work) . Furthermore, this domain is required when gelatinase-A is used in transfection experiments to promote the metastatic potential of cells (M. I. Cockett, unpublished work) . We therefore propose that gelatinase-A binds to the cell membrane via its C-terminal Volume 22 domain and that this can give rise to the metastatic phenotype following localized gelatinase-A activation (Figure 2) . A recent report that active gelatinase-A can be localized to the invadopodia of malignant cells [25] supports the view that active enzyme on the tumour cell surface may allow the focal hydrolysis of extracellular matrix at sites of cellular invasion.
Unlike collagenase or stromelysin, the gelatinase-A C-terminal domain is not required for substrate specificity or binding to matrix; in fact, a C-terminal truncated gelatinase-A appears catalytically identical to the full-length molecule on a variety of substrates [ 13, 
